Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Est. Listeners
Based on iTunes & Spotify (publisher stats).
- Per-Episode Audience
Est. listeners per new episode within ~30 days
25,001 - 50,000 - Monthly Reach
Unique listeners across all episodes (30 days)
75,001 - 150,000 - Active Followers
Loyal subscribers who consistently listen
40,001 - 100,000
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
NEJM Interview: Amanda Banks on concerns about a potential association between GLP-1 receptor agonists and restrictive eating disorders.
Apr 29, 2026
Unknown duration
Introducing: Intention to Treat — Season 2
Apr 29, 2026
Unknown duration
NEJM Interview: Sara Gerke on a Utah pilot program involving an AI system that autonomously renews certain prescriptions.
Apr 22, 2026
Unknown duration
NEJM Interview: Amy Stimpfel on a new policy that would cap loans for graduate nursing and other students.
Apr 15, 2026
Unknown duration
NEJM Interview: Danielle Jones on the development of tools to help family physicians address social determinants of health and advance health equity.
Apr 8, 2026
Unknown duration
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 4/29/26 |  NEJM Interview: Amanda Banks on concerns about a potential association between GLP-1 receptor agonists and restrictive eating disorders. | Amanda Banks is a consultant and a physician at the Corporal Michael J. Crescenz VA Medical Center. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. Banks. GLP-1 Receptor Agonists and Eating Disorders — Cause for Concern. N Engl J Med 2026;394:1665-1667. | — | ||||||
| 4/29/26 |  Introducing: Intention to Treat — Season 2 | What happens when medicine gets race wrong? In a new 8-week series, The Race Equation confronts harmful assumptions about race in clinical medicine, why they endure, and what it will take to change. | — | ||||||
| 4/22/26 | NEJM Interview: Sara Gerke on a Utah pilot program involving an AI system that autonomously renews certain prescriptions. | Sara Gerke is an associate professor of law and at the European Union Center at the University of Illinois Urbana-Champaign. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S. Gerke, R.B. Parikh, and I.G. Cohen. Utah’s Prescription-Renewal Pilot Program — Autonomous AI Managing Patient Care. N Engl J Med 2026;394:1561-1563. | — | ||||||
| 4/15/26 | NEJM Interview: Amy Stimpfel on a new policy that would cap loans for graduate nursing and other students. | Amy Stimpfel is an assistant professor at the New York University Rory Meyers College of Nursing. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.W. Stimpfel and M. Djukic. Using Data to Inform Decision Making — Borrowing Limits for Graduate Nursing Students. N Engl J Med 2026;394:1457-1459. P. Joseph and Others. Nurse Scientists as Trusted Voices in Health Communication. N Engl J Med 2026;394:1459-1461. | — | ||||||
| 4/8/26 | NEJM Interview: Danielle Jones on the development of tools to help family physicians address social determinants of health and advance health equity. | Danielle Jones is the vice president of accountability, belonging, and culture at the Association of Women's Health, Obstetric and Neonatal Nurses. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. W.T. Moore and Others. From Clinic to Community — The EveryONE Project in Family Medicine. N Engl J Med 2026;394:1353-1354. | — | ||||||
| 4/1/26 | NEJM Interview: Lawrence Casalino on qualities of corporate organizations that could affect physicians’ intrinsic motivation and the quality of the care they provide. | Lawrence Casalino is a professor of population health sciences at Weill Cornell Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L.P. Casalino. Physicians, Corporatization, and the Unmeasured Quality of Care. N Engl J Med 2026;394:1249-1251. | — | ||||||
| 3/25/26 | NEJM Interview: Douglas Opel on the importance of clinician–parent communication amid changes to the childhood vaccine schedule. | Douglas Opel is a professor in the Department of Pediatrics at the University of Washington School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.J. Opel and S.T. O’Leary. Communicating about Vaccines in a Politically Contentious Climate. N Engl J Med 2026;394:1145-1147. | — | ||||||
| 3/11/26 | NEJM Interview: Abbas Hassan on the gap between the services that residents and fellows provide and the revenue that hospitals can capture. | Abbas Hassan is a plastic surgery resident at the Indiana University School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.M. Hassan and J.F. Waljee. Valuing Care Provided by Residents and Fellows — Toward Competency-Based Billing. N Engl J Med 2026;394:1041-1043. | — | ||||||
| 3/4/26 | NEJM Interview: Ruqaiijah Yearby on recent trends in health care markets and their implications for health equity. | Ruqaiijah Yearby is a professor at the Temple University Beasley School of Law. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. R. Yearby and M. Alsan. Private Equity’s Transformation of American Medicine — Implications for Health Equity. N Engl J Med 2026;394:937-940. | — | ||||||
| 2/25/26 | NEJM Interview: Bruce Chabner on recent FDA statements regarding potential uses for leucovorin. | Bruce Chabner is a professor of medicine at Harvard Medical School and clinical director emeritus of the Massachusetts General Hospital Cancer Center. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. I.D. Goldman and B.A. Chabner. Cerebral Folate Deficiency, Autism, and the Role of Leucovorin. N Engl J Med 2026;394:833-835. | — | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 2/18/26 | NEJM Interview: Sonja Rasmussen on the 2025–2026 influenza season, including factors contributing to the intensity of influenza activity. | Sonja Rasmussen is a professor in the Department of Genetic Medicine at Johns Hopkins School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.A. Rasmussen and D.B. Jernigan. Antigenic Drift and Antivaccine Shift in the 2025–2026 Influenza Season. N Engl J Med 2026;394:732-735. | — | ||||||
| 2/11/26 | NEJM Interview: Carmel Shachar on the opportunities and risks presented by the Rural Health Transformation Program. | Carmel Shacharis an assistant clinical professor of law and faculty director of the Health Law and Policy Clinic at Harvard Law School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. H. Howard and C. Shachar. The Rural Health Transformation Program — An Avenue for Promoting Administrative Policies. N Engl J Med 2026;394:625-627. | — | ||||||
| 2/4/26 | NEJM Interview: Leemore Dafny on the implications of corporatization of the U.S. health insurance industry. | Leemore Dafny is a professor of business administration at Harvard Business School and a professor of public policy at the Harvard Kennedy School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L. Dafny. Health Insurance after Corporatization — What Next? N Engl J Med 2026;394:521-523. | — | ||||||
| 1/28/26 | NEJM Interview: Robert Kocher on strategies for improving blood-pressure control in the United States. | Robert Kocher is an adjunct professor at the Stanford University School of Medicine, a nonresident senior scholar at the University of Southern California Schaeffer Institute, and a partner at Venrock. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.P. Kishore and R. Kocher. The Hypertension Control Paradox — Why Is America Stuck? N Engl J Med 2026;394:417-420. | — | ||||||
| 1/21/26 | NEJM Interview: Tara Eicher on changes in autism diagnosis in recent years and statements from the federal government regarding autism. | Tara Eicher is a postdoctoral research fellow in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T. Eicher, J. Quackenbush, and A. Ne’eman. Challenging Claims of an Autism Epidemic — Misconceptions and a Path Forward. N Engl J Med 2026;394:313-315. | — | ||||||
| 1/14/26 | NEJM Interview: Tara Sklar on U.S. telehealth payment policy and the potential for a revised approach to support competition and efficiency. | Tara Sklar is the faculty director of the Health Law and Policy Program at the University of Arizona James E. Rogers College of Law and associate director of telehealth law and policy at the University of Arizona College of Medicine–Tucson Arizona Telemedicine Program. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T. Sklar and B. Richman. Financing Telehealth — Moving Beyond Payment Parity. N Engl J Med 2026;394:211-213. | — | ||||||
| 1/7/26 | NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States. | Rachel Sachs is a professor of law at Washington University in St. Louis. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.B. Dusetzina and R.E. Sachs. Insurance Coverage and Pricing of Weight-Loss Drugs in the United States. N Engl J Med 2026;394:105-107. S. Gondi, A.S. Kesselheim, and B.N. Rome. Generic Liraglutide — Overlooked but Not Forgotten. N Engl J Med. DOI: 10.1056/NEJMp2515668. | — | ||||||
| 12/31/25 | NEJM Interview: Ambar La Forgia on the drivers and effects of corporatization of outpatient medical services. | Ambar La Forgia is an assistant professor in the Management of Organizations group at the University of California, Berkeley Haas School of Business. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. La Forgia. From Patients to Consumers — The Corporatization of Ambulatory Care. N Engl J Med 2026;394:1-3. | — | ||||||
| 12/17/25 | NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend. | Anne Zink is a lecturer and senior fellow at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.B. Zink, N.C. McCann, and R.P. Walensky. From Crisis to Action — Policy Pathways to Reverse the Rise in Congenital Syphilis. N Engl J Med 2025;393:2388-2391. | — | ||||||
| 12/10/25 | NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure. | Reshma Ramachandran is an assistant professor of medicine at the Yale School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.D. Wallach, J.S. Ross, and R. Ramachandran. Enhancing FDA Drug-Safety Surveillance — Beyond Releasing Daily Adverse-Event Data. N Engl J Med 2025;393:2284-2286. | — | ||||||
| 12/3/25 | NEJM Interview: Robert Huckman on the dearth of successful business models aimed at keeping people healthy. | Robert Huckman is a professor of business administration at Harvard Business School and a research associate at the National Bureau of Economic Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.M. Cutler and R.S. Huckman. Has Corporatization Met Its Match? The Challenge of Making Money by Keeping People Healthy. N Engl J Med 2025;393:2177-2180. | — | ||||||
| 11/26/25 | NEJM Interview: Nishant Uppal on the emergence of venture capital investing by academic medical centers and its potential implications. | Nishant Uppal is an instructor in medicine at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. N. Uppal and Z. Song. Venture Capital Investments by U.S. Academic Medical Centers. N Engl J Med 2025;393:2077-2080. | — | ||||||
| 11/19/25 | NEJM Interview: Jane Zhu on a new Oregon law that aims to address corporate control in medicine. | Jane Zhu is an associate professor of medicine in the Division of General Internal Medicine at Oregon Health and Science University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.M. Zhu and H. Rooke-Ley. Regulating Corporate Control in Health Care — Oregon’s Attempt to Revive the CPOM Doctrine. N Engl J Med 2025;393:1972-1974. | — | ||||||
| 11/12/25 | NEJM Interview: Joshua Barocas on recent federal actions related to harm-reduction programs for people with substance use disorders. | Joshua Barocas is an associate professor of medicine at the University of Colorado Anschutz Medical Campus. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.A. Barocas. The Erosion of Harm Reduction. N Engl J Med 2025;393:1865-1867. B.A. Barsky, A. Caplan-Bricker, and C. Robertson. Religious Liberty as a Shield for Public Health — The Case of Overdose-Prevention Centers. N Engl J Med 2025;393:1867-1869. | — | ||||||
| 11/5/25 | NEJM Interview: Yashaswini Singh on antitrust enforcement as a potential counterbalance to consolidation resulting from rapid health care corporatization. | Yashaswini Singh is an assistant professor of health services, policy, and practice at Brown University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. Y. Singh. The Antitrust Antidote to Hospital and Nursing Home Corporatization — Promises and Pitfalls. N Engl J Med 2025;393:1761-1764. | — | ||||||
Showing 25 of 936
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
8 placements across 8 markets.
Chart Positions
8 placements across 8 markets.